• Home
Scientific article
English

Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose

ContributorsChristoph, Patricia; Schuller, Christine; Studer, Hanna; Irion, Olivier; Martinez De Tejada Weber, Begona; Surbek, Daniel
Published inJournal of perinatal medicine, vol. 40, no. 5, p. 469-474
Publication date2012
Abstract

Oral iron substitution has shown to be insufficient for treatment of severe iron deficiency anemia in pregnancy. Ferric carboxymaltose is a new intravenous (i.v.) iron formulation promising to be more effective and as safe as iron sucrose. We aimed to assess side effects and tolerance of ferric carboxymaltose compared to i.v. iron sucrose in pregnant women.

Keywords
  • Administration, Intravenous
  • Adolescent
  • Adult
  • Anemia/drug therapy
  • Female
  • Ferric Compounds/administration & dosage
  • Glucaric Acid/administration & dosage
  • Hematinics/administration & dosage
  • Humans
  • Maltose/administration & dosage/analogs & derivatives
  • Middle Aged
  • Pregnancy
  • Pregnancy Complications, Hematologic/drug therapy
  • Retrospective Studies
  • Young Adult
Affiliation entities
Research groups
Citation (ISO format)
CHRISTOPH, Patricia et al. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. In: Journal of perinatal medicine, 2012, vol. 40, n° 5, p. 469–474. doi: 10.1515/jpm-2011-0231
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0300-5577
613views
0downloads

Technical informations

Creation12/04/2013 6:20:00 PM
First validation12/04/2013 6:20:00 PM
Update time03/14/2023 8:42:00 PM
Status update03/14/2023 8:42:00 PM
Last indexation10/30/2024 3:17:02 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack